Industry Outlook and Trend Analysis
The Breast Biopsy Device Market was worth USD 0.38 billion in the year 2012 and is expected to reach approximately USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39% during the forecast period. It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques. The expansion in the recurrence of breast cancers in women worldwide, and in addition the ascent in awareness of cancer screening programs is a portion of the components that are assessed to add to the market development over the gauged time frame. Furthermore, the various kinds of product improvement, ceaselessly propelled in the market are additionally anticipated that would positively affect this industry amid the estimated time frame. For example, C.R Bard's Mission Truguide disposable coaxial biopsy needles, made of ultrathin walls, give high effectiveness and precision in the securing of sample tissue. Nonetheless, the dangers engaged with the methodology are probably going to influence the Breast Biopsy Device Market contrarily. The level of hazard considers the invasiveness of the method utilized. Surgical core methods may be more precise and successful however it includes real dangers. Besides, roughly 60%to 80% of the biopsies acquired are generous. Subsequently, women are urged to take a second opinion before experiencing any such surgical strategies, which thusly is relied upon to contrarily influence the market development.
Get Free Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54912
Procedure Type Outlook and Trend Analysis
Based on the type of the procedure, this market industry is categorized into open surgical and needle breast biopsies. The latter is additionally classified into core-needle biopsy, fine-needle biopsy and vacuum-assisted Biopsy. Owing to the ascending demand for minimally invasive procedures, in 2015 the fine-needle aspiration segment was accountable for a greater marker share. Fine-needle aspiration biopsy is the simplest form of breast biopsy done and mostly performed to rule out lump which can be felt at the time of clinical breast exam. The procedure involves thin needle (with syringe) being directly injected into the lump to collect cell samples. On the other hand, due to the less-invasive nature of the procedure, the vacuum-assisted core biopsy is expected to bud at a considerable higher CAGR during the forecast period. The procedure involves a minor incision through which the needle is injected, following which the sample is collected with the help of a vacuum-powered device. Also, core-needle biopsy is gradually being performed more as a breast biopsy and is anticipated to stay predominant sub-segment as compared to others. Owing to the invasiveness of open surgical breast biopsy, which are of two types, i.e., incisional and excisional breast biopsies, these procedures are less preferred unless in extreme cases. Incisional biopsy extracts a particular part from the suspicious area which is sufficient for diagnosis. Whereas, excisional biopsy removes complete part of the abnormal, tumor area, either with or without taking an edge of the normal breast tissue.
Product Outlook and Trend Analysis
The key products utilized for breast biopsy are guidance systems, localization wires, biopsy tables and needles among others. In 2015, the needles segment possessed a major share. This development is accountable to its wide relevance in the needle breast biopsy market. A large portion of the developments and progressions are seen in the products section. For example, the Stryker PreciseCore needle lets sample collection with higher accuracy and with far less risks of tissue damage included. Moreover, the guidance system product section is foreseen to witness a high development rate amid the projected time frame. In needles, the fine needle aspiration makes use of a very small needle to remove cells or liquid from the abnormal part and the core needle make the use of a big hollow needle to extract one sample of the breast in every insertion. In localization wires a guide wire is put into the suspicious part to assist the surgeon to detect the lesion for surgical biopsy.
Guidance Type Outlook and Trend Analysis
The biopsy methods require guidance systems to find the irregularity or lumps in the breast area. The accessible guiding systems utilized for biopsies incorporate the magnetic resonance guided biopsies, ultrasound-guided, and mammography-guided stereotactic among others that guide with the technique in identifying and finding the existence of unusual cell developments. The mammography-guided portion adds to the biggest share in the industry. Nonetheless, the likelihood of false positive outcomes related with the imaging of breast tissues that are dense is generally high. The ultrasound-guided method yields more exact outcomes and is foreseen to witness the most striking development rate amid the forecast period.
Regional Outlook and Trend Analysis
North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2015 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2012, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world. In EU-28 of The European Breast Cancer Coalition, it has been stated that in 2012, 361,600 breast cancer cases were registered. Also, one in every eight women in the EU-28 is expected to acquire breast cancer before the age of 85.
Competitive Insights
Some major players in the market are Devicor Medicals Products, Inc, C. R. Bard, Inc., OncoCyte Corporation, Stryker International, Inc., Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Hologic Inc, and Laboratory Corporation of America Holdings (Labcorp). These organizations are extensively inclined in the enhancement of new products, decreasing the cost of production and in implementing strategies like approvals from the Food and Drug Administration, acquisitions and mergers in order to upkeep their position in the industry. For example, Hologic, Inc declared its approval from the Food and Drug Administration for the Affirm Prone biopsy system that is commercially available. The new product is a guided system that is equipped with 2D/3D imaging characteristics.
Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54912
The global Breast Biopsy Devices market is segmented as follows:
By Procedure Type
Needle Breast Biopsy
Core-needle Biopsy
Fine-needle Aspiration Biopsy
Vacuum-assisted Biopsy
Open Surgical Breast Biopsy
Excisional Breast Biopsy
Incisional Breast Biopsy
By Product
Guidance Systems
Biopsy Tables
Localization Wires
Biopsy Needles
Others (Punches, Markers, Sutures)
By Guidance Type
Ultrasound-guided Breast Biopsy
Mammography-guided Stereotactic Breast Biopsy
Magnetic Resonance-guided Breast Biopsy
Others (thermography, PET)
By Region
North America
U.S
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
Rest of the World
Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others
Some of the key questions answered by the report are:
What was the market size in 2012 and forecast from 2013 to 2022?
What will be the industry market growth from 2013 to 2022?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Get Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-54912